Form D · Other Health Care

PharmID, Inc.

Seattle, WA · CIK 0001719289

Offering snapshot reported Feb 18, 2020 · SEC filing

Reported sold
$5M
Offering amount: $5M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 13, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.5M$5MJul 26, 2018: $382,589.00Jul 26, 2018Feb 18, 2020: $4,999,996.00Feb 18, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$382,589 → $4,999,996
  • Reported investors4 → 13

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 18, 2020Amendment$4,999,996$4,617,407vs Jul 26, 201813SEC filing
Jul 26, 2018Initial$382,589No comparison4SEC filing
Oct 11, 2017Initial$1,045,000No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-317795

Source: Form D, filed Feb 18, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tim Gibbons Director, Executive
Brian Marquardt Director, Executive
Tom Pierson Executive
Christopher Swasand Director
Scott Van Vuren Director
J. Scott Van Vuren Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2157 N. Northlake Way #240
Seattle, WA, 98103